Product Information
GS ALL DAY ALLERGY-D TABLET is a generic product labeled by L. Perrigo Company, priced at $0.5625 per EA under NDC 00113014762. Its NADAC has been published 161 times since Sep 6, 2023.
FDA first approved this application on Nov 16, 2018.
Strength
5; 120 mg/1; mg/1
Manufacturer
L. Perrigo CompanyNDC
00113014762
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210719FDA Approved
11/16/2018
On Market Since
12/27/2020
Pharmacological Classes
Price Statistics
The NADAC for GS ALL DAY ALLERGY-D TABLET has been published 161 times since Sep 6, 2023, and over the history we have for it it has declined 9.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5625 per EA |
|---|---|
| All-time high | $0.6314 (Feb 14, 2024) |
| All-time low | $0.5313 (Nov 20, 2024) |
| 52-week high | $0.5956 |
| 52-week low | $0.5617 |
| Median price | $0.5797 |
| Average price | $0.5819 |
| Largest weekly change | +10.3% (Jun 19, 2024) |
| Weeks tracked | 161 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cetirizine hydrochloride, Pseudoephedrine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS ALL DAY ALLERGY-D TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GS ALL DAY ALLERGY-D TABLET, manufactured by L. Perrigo Company, is $0.5625 per EA (NDC 00113014762), effective Sep 30, 2026.
How has the price of GS ALL DAY ALLERGY-D TABLET changed over time?
Over the history we have for it, the NADAC for GS ALL DAY ALLERGY-D TABLET has declined 9.2%. It has been tracked across 161 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for GS ALL DAY ALLERGY-D TABLET?
Since Sep 6, 2023, the NADAC for GS ALL DAY ALLERGY-D TABLET has ranged from a low of $0.5313 (Nov 20, 2024) to a high of $0.6314 (Feb 14, 2024), with a median of $0.5797 per EA.
Are there cheaper alternatives to GS ALL DAY ALLERGY-D TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS ALL DAY ALLERGY-D TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GS ALL DAY ALLERGY-D TABLET?
GS ALL DAY ALLERGY-D TABLET (NDC 00113014762) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.